DARTMOUTH-HITCHCOCK MEDICAL CENTER

DARTMOUTH-HITCHCOCK MEDICAL CENTER logo
🇺🇸United States
Ownership
Private, Subsidiary
Established
1983-01-01
Employees
10K
Market Cap
-
Website
http://www.dartmouth-hitchcock.org

Study of Tarceva and Targretin in Stage I-II Lung Cancer

First Posted Date
2005-08-01
Last Posted Date
2019-01-08
Lead Sponsor
Dartmouth-Hitchcock Medical Center
Target Recruit Count
12
Registration Number
NCT00125372
Locations
🇺🇸

Norris Cotton Cancer Center, Lebanon, New Hampshire, United States

Mitomycin and Mitoxantrone in Treating Patients With Acute Myelogenous Leukemia

Phase 1
Completed
Conditions
First Posted Date
2004-08-12
Last Posted Date
2018-03-19
Lead Sponsor
Dartmouth-Hitchcock Medical Center
Target Recruit Count
29
Registration Number
NCT00003003
Locations
🇺🇸

Norris Cotton Cancer Center, Lebanon, New Hampshire, United States

Vaccine Therapy in Treating Patients With Stage III or Stage IV Melanoma

Phase 1
Completed
Conditions
First Posted Date
2004-06-11
Last Posted Date
2015-02-02
Lead Sponsor
Dartmouth-Hitchcock Medical Center
Registration Number
NCT00085488
Locations
🇺🇸

Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States

Cyclophosphamide, Fludarabine, and High-Dose Interleukin-2 in Treating Patients With Metastatic Melanoma

First Posted Date
2004-06-11
Last Posted Date
2013-04-10
Lead Sponsor
Dartmouth-Hitchcock Medical Center
Target Recruit Count
20
Registration Number
NCT00085423
Locations
🇺🇸

Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States

DC Vaccine Combined With IL-2 and IFNα-2a in Treating Patients With mRCC

First Posted Date
2004-06-11
Last Posted Date
2018-06-26
Lead Sponsor
Dartmouth-Hitchcock Medical Center
Target Recruit Count
18
Registration Number
NCT00085436
Locations
🇺🇸

Norris Cotton Cancer Center at Dartmouth - Hitchcock Medical Center, Lebanon, New Hampshire, United States

Lepirudin in Treating Patients With Recurrent or Advanced Small Cell Lung Cancer

Phase 1
Terminated
Conditions
Interventions
First Posted Date
2004-05-03
Last Posted Date
2016-08-08
Lead Sponsor
Dartmouth-Hitchcock Medical Center
Target Recruit Count
1
Registration Number
NCT00003726
Locations
🇺🇸

Norris Cotton Cancer Center, Lebanon, New Hampshire, United States

Gefitinib With or Without Tamoxifen in Treating Patients With Tamoxifen-Resistant Metastatic Breast Cancer

First Posted Date
2004-04-08
Last Posted Date
2009-08-06
Lead Sponsor
Dartmouth-Hitchcock Medical Center
Target Recruit Count
2
Registration Number
NCT00080743
Locations
🇺🇸

Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States

Combination Chemotherapy for Patients With Brain Cancer

Phase 2
Completed
Conditions
First Posted Date
2004-04-06
Last Posted Date
2011-10-27
Lead Sponsor
Dartmouth-Hitchcock Medical Center
Target Recruit Count
20
Registration Number
NCT00002814
Locations
🇺🇸

Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States

Chemotherapy Plus Trastuzumab in Treating Patients With Breast Cancer

Phase 1
Completed
Conditions
First Posted Date
2004-02-16
Last Posted Date
2013-03-14
Lead Sponsor
Dartmouth-Hitchcock Medical Center
Target Recruit Count
13
Registration Number
NCT00014430
Locations
🇺🇸

Norris Cotton Cancer Center, Lebanon, New Hampshire, United States

Temozolomide Plus PEG-Interferon Alfa-2B in Treating Patients With Advanced Solid Tumors

First Posted Date
2003-07-30
Last Posted Date
2018-03-30
Lead Sponsor
Dartmouth-Hitchcock Medical Center
Registration Number
NCT00014261
Locations
🇺🇸

Norris Cotton Cancer Center, Lebanon, New Hampshire, United States

© Copyright 2024. All Rights Reserved by MedPath